LRI Investments’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.18K Sell
118
-64
-35% -$1.89K ﹤0.01% 1174
2026
Q1
$5.04K Buy
+182
New +$4.67K ﹤0.01% 1097

Other funds holding ROIV

LRI Investments's ROIV Position: Q2 2026 in Review

LRI Investments reduced its Roivant Sciences (ROIV) stake by 35% in Q2 2026, selling an estimated $1.89K and leaving 118 shares worth $4.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

LRI Investments first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.04K in Q1 2026. 143 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • LRI Investments held 118 shares of Roivant Sciences worth $4.18K as of Q2 2026.
  • LRI Investments sold 64 Roivant Sciences shares in Q2 2026, an estimated $1.89K.
  • Roivant Sciences made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1174 holding.
  • LRI Investments first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • LRI Investments's Roivant Sciences position peaked at $5.04K in Q1 2026.
  • 143 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.